The IQVIA Institute for Human Data Science has released a new report which features a Reopening Readiness Index (RPI). It presents five criteria for easing restrictions in the United States and generates an aggregate readiness score based on progress in each category. The result is a consistent way to assess current readiness and to track progress – or regression – over time.
Thirteen states reach an aggregate score of 90 or more against an index level of 100 points; New York, Rhode Island, and New Jersey are the only states to meet or exceed that score, due in large part to high levels of testing and low current reproduction rates.
To compliment the RPI, IQVIA has also released a Health Services Utilization Index (HSUI), which measures the utilization of five key health services - including doctor visits, elective procedures and new prescriptions – as a signal of revival for the health system.
The HSUI shows must states are utilizing these key health services half as much as they did prior to COVID-19. This suggests that many patients are still facing delayed or deferred medical treatments. The revival of the health system is critical to ensuring all Americans receive treatments and/or prescriptions they need.
For the detailed IQVIA Reopening Readiness Index, click here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.